Histological and mutational profile of diffuse gastric cancer: current knowledge and future challenges
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Histological and mutational profile of diffuse gastric cancer: current knowledge and future challenges
Authors
Keywords
-
Journal
Molecular Oncology
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-03-16
DOI
10.1002/1878-0261.12948
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integrated characterisation of cancer genes identifies key molecular biomarkers in stomach adenocarcinoma
- (2020) Haifeng Wang et al. JOURNAL OF CLINICAL PATHOLOGY
- Clinical relevance of somatic mutations in main driver genes detected in gastric cancer patients by next-generation DNA sequencing
- (2020) Marina V. Nemtsova et al. Scientific Reports
- Molecular profiling for precision cancer therapies
- (2020) Eoghan R. Malone et al. Genome Medicine
- Hispanic/Latino Patients with Gastric Adenocarcinoma Have Distinct Molecular Profiles Including a High Rate of Germline CDH1 Variants
- (2020) Sam C. Wang et al. CANCER RESEARCH
- Integrated immune gene expression signature and molecular classification in gastric cancer: New insights
- (2020) Maria Grazia Refolo et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Clinical characteristics and prognostic significance of TCGA and ACRG classification in gastric cancer among the Chinese population
- (2020) Qiang Wang et al. Molecular Medicine Reports
- Are Immunohistochemical Markers Useful in Phenotypic Gastric Cancer Classification?
- (2020) Federica Di Pinto et al. ONCOLOGY
- An Integrative Morphomolecular Classification System of Gastric Carcinoma With Distinct Clinical Outcomes
- (2020) Jia-Huei Tsai et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Epstein–Barr virus-associated gastric cancer: disease that requires special approach
- (2020) Ekaterina Ignatova et al. Gastric Cancer
- Hereditary diffuse gastric cancer: updated clinical practice guidelines
- (2020) Vanessa R Blair et al. LANCET ONCOLOGY
- A Molecular Stratification of Chilean Gastric Cancer Patients with Potential Clinical Applicability
- (2020) Mauricio P. Pinto et al. Cancers
- Protein expression-based classification of gastric cancer by immunohistochemistry of tissue microarray
- (2020) Chong Zhao et al. PLoS One
- MUC4 , MUC16 , and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer
- (2020) Yue Yang et al. Clinical and Translational Medicine
- Recent advances in the pathology of heritable gastric cancer syndromes
- (2020) Irene Gullo et al. HISTOPATHOLOGY
- Epigenomic promoter alterations predict for benefit from immune checkpoint inhibition in metastatic gastric cancer
- (2019) R Sundar et al. ANNALS OF ONCOLOGY
- CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer
- (2019) Andrea Rebeca Bustos-Carpinteyro et al. BMC CANCER
- Enrichment of CLDN18 -ARHGAP fusion gene in gastric cancers in young adults
- (2019) Izuma Nakayama et al. CANCER SCIENCE
- A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study
- (2019) O Türeci et al. ANNALS OF ONCOLOGY
- Development and Validation of an Easy‐to‐Implement, Practical Algorithm for the Identification of Molecular Subtypes of Gastric Cancer: Prognostic and Therapeutic Implications
- (2019) Jiwon Koh et al. ONCOLOGIST
- Genome-wide analysis to identify a novel distant metastasis-related gene signature predicting survival in patients with gastric cancer
- (2019) Bang-li Hu et al. BIOMEDICINE & PHARMACOTHERAPY
- Dissection of gastric cancer heterogeneity for precision oncology
- (2019) Shamaine Wei Ting Ho et al. CANCER SCIENCE
- Somatic Selection Distinguishes Oncogenes and Tumor Suppressor Genes
- (2019) Pramod Chandrashekar et al. BIOINFORMATICS
- Cancer gene profiling explores the possible precision medicine for diffuse-type gastric adenocarcinoma
- (2019) Marin Ishikawa et al. MEDICAL ONCOLOGY
- Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer
- (2018) Elke J. A. H. van Beek et al. ANNALS OF SURGICAL ONCOLOGY
- Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial
- (2018) Hironori Ishigami et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
- (2018) Seung Tae Kim et al. NATURE MEDICINE
- Characterization of long non-coding RNAs and MEF2C-AS1 identified as a novel biomarker in diffuse gastric cancer
- (2018) Tianhang Luo et al. Translational Oncology
- Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer
- (2018) Yang Shu et al. Nature Communications
- Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma
- (2018) C. Mariette et al. Gastric Cancer
- What’s New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives
- (2018) Giuseppe Tirino et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD‐L1
- (2018) Lola Fashoyin‐Aje et al. ONCOLOGIST
- Immunohistochemical classification of gastric cancer based on new molecular biomarkers: a potential predictor of survival
- (2018) Cristina Díaz del Arco et al. VIRCHOWS ARCHIV
- Genetic analysis of a case of Helicobacter pylori-uninfected intramucosal gastric cancer in a family with hereditary diffuse gastric cancer
- (2018) Taro Funakoshi et al. Gastric Cancer
- Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers
- (2017) Soo Young Cho et al. GASTROENTEROLOGY
- Gastric poorly cohesive carcinoma: a correlative study of mutational signatures and prognostic significance based on histopathological subtypes
- (2017) Chae H Kwon et al. HISTOPATHOLOGY
- Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Yoon-Koo Kang et al. LANCET
- Heterogeneity in Gastric Cancer: From Pure Morphology to Molecular Classifications
- (2017) Irene Gullo et al. PATHOBIOLOGY
- Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics
- (2017) Eva-Maria Birkman et al. VIRCHOWS ARCHIV
- Early detection of gastric cancer using global, genome-wide and IRF4, ELMO1, CLIP4 and MSC DNA methylation in endoscopic biopsies
- (2017) Francesca Pirini et al. Oncotarget
- Molecular classifications of gastric cancers: Novel insights and possible future applications
- (2017) Silvio Ken Garattini et al. World Journal of Gastrointestinal Oncology
- Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) E. C. Smyth et al. ANNALS OF ONCOLOGY
- Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma
- (2016) Raul S. Gonzalez et al. HUMAN PATHOLOGY
- Mixed Carcinoma as an Independent Prognostic Factor in Submucosal Invasive Gastric Carcinoma
- (2016) Hyung Kyu Park et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- A protein and mRNA expression-based classification of gastric cancer
- (2016) Namrata Setia et al. MODERN PATHOLOGY
- Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity
- (2016) Wen Fong Ooi et al. Nature Communications
- Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
- (2015) Razvan Cristescu et al. NATURE MEDICINE
- Copy Number Gains at 8q24 and 20q11-q13 in Gastric Cancer Are More Common in Intestinal-Type than Diffuse-Type
- (2015) Dong-Hao Jin et al. PLoS One
- Targeting p300 Addiction in CBP-Deficient Cancers Causes Synthetic Lethality by Apoptotic Cell Death due to Abrogation of MYC Expression
- (2015) H. Ogiwara et al. Cancer Discovery
- Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy
- (2015) Ismael Riquelme et al. Oncotarget
- jvenn: an interactive Venn diagram viewer
- (2014) Philippe Bardou et al. BMC BIOINFORMATICS
- Comprehensive characterization of the genomic alterations in human gastric cancer
- (2014) Juan Cui et al. INTERNATIONAL JOURNAL OF CANCER
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Treatment of gastric cancer
- (2014) Michele Orditura WORLD JOURNAL OF GASTROENTEROLOGY
- Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
- (2013) Edward Y Chen et al. BMC BIOINFORMATICS
- Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas – PRODIGE 19 – FFCD1103 – ADCI002
- (2013) Guillaume Piessen et al. BMC CANCER
- Targeting BCL-2 with the BH3 Mimetic ABT-199 in Estrogen Receptor-Positive Breast Cancer
- (2013) François Vaillant et al. CANCER CELL
- Identification of Molecular Subtypes of Gastric Cancer With Different Responses to PI3-Kinase Inhibitors and 5-Fluorouracil
- (2013) Zhengdeng Lei et al. GASTROENTEROLOGY
- Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer: Results From a Randomized, Placebo-Controlled, Parallel-Arm, Phase II Trial
- (2013) Jin Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer
- (2012) Ian J Majewski et al. JOURNAL OF PATHOLOGY
- Intrinsic Subtypes of Gastric Cancer, Based on Gene Expression Pattern, Predict Survival and Respond Differently to Chemotherapy
- (2011) Iain Beehuat Tan et al. GASTROENTEROLOGY
- Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737
- (2011) S. R. Oakes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- A combined histologic and molecular approach identifies three groups of gastric cancer with different prognosis
- (2009) Enrico Solcia et al. VIRCHOWS ARCHIV
- Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas
- (2008) Hua-chuan Zheng et al. VIRCHOWS ARCHIV
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started